On-Site Nitrogen for Medicinal Production
Nitrogen Generator for Medicinal Manufacturing, USA-Built
On-site nitrogen for small-molecule drug production, biologics, sterile compounding, and vaccine manufacturing. 99% to 99.9995% purity at the manifold, a built-in oxygen analyzer logging purity for batch records, and one continuous, auditable gas source for validated production.
Process-gas purity range
Continuous purity log for batch records
Typical payback
Service life
On-site nitrogen for medicinal production lines. Vial and ampoule purging, lyophilization backfill, and reactor blanketing at 99% to 99.9995% purity, with a built-in oxygen analyzer logging buffer-tank purity for batch records.
Process Gas for Medicinal Production
Medicinal manufacturing has a continuous, on-spec nitrogen problem
Reactor batches that run for hours under inert headspace, lyophilizer cycles that break vacuum with dry nitrogen rather than ambient air, and sterile-fill lines that purge every vial before stoppering all share one supply problem: cylinder and dewar gas runs out. A switch mid-reactor is a quality event that sends the batch to investigation. A delivery delay during a lyo cycle compromises a freeze-dry. Every delivered lot also arrives with its own certificate of analysis to file and reconcile. On-site generation removes the supply variable entirely so the production line sees one continuous nitrogen source at the manifold.
Six places nitrogen earns its keep in medicinal production: reactor blanketing over small-molecule synthesis, lyophilization backfill for freeze-dried injectables and biologics, sterile-fill line purging of vials, ampoules, and syringes, tablet coating on solvent-based and aqueous lines, cleanroom and isolator inerting for oxygen-sensitive API handling, and bulk drug substance sparging to strip dissolved oxygen from process solvents. The same generator can supply more than one of these from a common buffer tank when the peak flows and required purities overlap.
Switching to on-site replaces cylinder, dewar, and bulk liquid deliveries with a continuous source rated for 20 years or more, recovers the investment in 12 to 14 months at typical production duty, and removes the batch-interruption risk that comes with running out of gas mid-cycle. Every system we supply includes a built-in oxygen analyzer in the buffer tank, so each batch record can attach a continuous purity log without extra instrumentation. Made in USA. In business since 1979.
Pharmaceutical Industry: plant-wide process gas
For the industry-wide view of pharma process gas: reactor blanketing, lyo vacuum break, tablet and film coating, sparging and API drying, cleanroom inerting, and autoclave and sterilizer cycles across the whole plant.
Open the pharma industry page →Medical Devices and Pharma Packaging: downstream finishing
For nitrogen on the finishing side: blister and vial headspace flush, sterile barrier packaging, lyo backfill on the closed-container side, and ethylene oxide sterilization purges on packaging lines.
Open the packaging page →By Application
Six places nitrogen earns its keep in medicinal production
Six process-gas applications across medicinal product manufacturing. The same generator can supply more than one of these from a common buffer tank when peak flows and required purities overlap.
Reactor blanketing
Inert headspace over batch reactors, hold tanks, and crystallizers running small-molecule synthesis. Continuous low-flow nitrogen on the reactor manifold maintains positive pressure throughout the batch and protects product chemistry from atmospheric oxygen ingress on charging and discharging.
- Typical purity99% to 99.99%
- Flow patternContinuous low-flow on manifold
Lyophilization backfill
At the end of a freeze-drying cycle, the chamber vacuum is broken with nitrogen rather than ambient air so the freeze-dried cake finishes under inert headspace. Standard practice for biologics, monoclonal antibodies, and oxygen-sensitive small-molecule injectables. The cycle peak at backfill drives buffer-tank sizing.
- Typical purity99.99% or higher
- Demand patternCycle peak at backfill
Sterile-fill line purging
Vials, ampoules, and syringes purged with nitrogen before fill and stoppering so the container headspace finishes inert. Direct product-contact service on injectables drives the purity specification, and the line draws steady flow for the duration of the fill shift.
- Typical purity99.99%
- Flow patternSteady flow during fill shift
Tablet coating
Inerting on solvent-based and aqueous tablet and film coaters protects oxygen-sensitive API cores and prevents solvent vapor from approaching the lower flammability limit inside the coating drum. Continuous nitrogen at the drum keeps the recirculation-loop oxygen reading within the validated margin.
- Typical purity99% to 99.5%
- Flow patternContinuous during coater run
Cleanroom and isolator inerting
Inert headspace in classified isolator chambers, RABS enclosures, and weighing booths handling oxygen-sensitive APIs and sterile compounding work. Lower flow than reactor or coater service, but a tight residual oxygen specification at the point of use because the chamber atmosphere is held inert during operator transfers.
- Typical purity99.99%
- Flow patternContinuous low-flow into chamber
Bulk drug substance sparging
Sparging through process solvents and product streams to strip dissolved oxygen before charging an oxygen-sensitive reaction or holding bulk drug substance. Runs during defined process steps rather than continuously, with the flow set by vessel volume and the target dissolved-oxygen level.
- Typical purity99% to 99.5%
- Flow patternStep-defined high flow
Purity by Use
Pick the lowest purity that meets your process spec
Higher purity costs more compressed air per cubic foot of nitrogen produced. Sizing the system to the highest purity any one line actually needs (not the highest in the catalog) keeps both equipment cost and operating cost down across the plant.
A/N ~2.8
Reactor blanket and process purges
Reactor blanket on standard APIs, sparging through process solvents, autoclave purge.
A/N ~3.4
General production inerting
General process inerting where additional headroom against the product spec is wanted, EO sterilizer chamber backfill, API drying.
A/N ~4.6
Sensitive APIs and sterile fill
Oxygen-sensitive APIs, isolator chamber inerting, lyo backfill on standard injectables, sterile-fill line purging.
A/N ~5.8 and up
Biologics and vaccine fill
Lyophilization backfill on biologics with tight residual O2 spec, vaccine and monoclonal antibody fill. Highest purity, highest air cost.
PSA from compressed air
Pressure swing adsorption pulls nitrogen from compressed shop air. Two beds of carbon molecular sieve adsorb oxygen under pressure while the second bed regenerates at low pressure. The cycle alternates so the manifold sees a continuous flow of dry, oil-free nitrogen.
Output is rated at the nameplate purity continuously, not just at a peak. Every system includes a built-in oxygen analyzer continuously logging buffer-tank purity, so each batch record can attach a continuous purity log without adding a third-party instrument to the line.
Why the air-to-nitrogen ratio matters
Producing 99% nitrogen takes about 2.8 cubic feet of compressed air per cubic foot of nitrogen. Producing 99.999% takes roughly twice that. The compressor sized for the higher purity is materially larger and burns more electricity for the life of the system.
If only the lyo line on the floor needs 99.999% and every other process runs at 99.99% or below, it is often cheaper to size the main generator to the lower-purity loads and run a small dedicated cabinet for the lyo than to push the whole plant up to the high-purity tier.
Sizing and Payback
Three numbers to size, three numbers to justify
Medicinal production sizing is straightforward when the process list is in front of you. Sum the per-process peak flows at each purity tier, add buffer for cycle peaks, and match a generator that holds spec at the highest tier any process needs. Three inputs drive the build, three drivers drive the payback, and the worked example below shows how a typical multi-suite plant lands.
Sizing inputs
- 1. Peak nitrogen flow per process SCFH or SCFM at the reactor manifold, lyo chamber backfill peak, fill-line inlet, or sterilizer chamber during the busiest cycle phase.
- 2. Required purity per process The process specification or chamber qualification, not the highest purity in the catalog. Tablet coater 99%, reactor 99.99%, lyo backfill 99.999%.
- 3. Required pressure at point of use Most reactor and coater service runs 60 to 100 PSIG. Lyo and isolator service runs lower. High-pressure service requires a separate booster.
Payback drivers
- Cylinder and dewar avoidance Per-CCF delivered-gas cost runs roughly $6 to $10 per CCF for cylinders and $4 to $6 per CCF for dewars. On-site nitrogen runs roughly $0.05 to $0.15 per CCF, or up to a 90% reduction.
- Change-out labor and traffic No forklift moves, no hose disconnects, no manifold rotation. Validation gets one source to qualify, not a rotating supplier list.
- Batch interruption avoided A reactor batch held mid-cycle on a manifold dip is a CAPA and an investigation. A lyo backfill that misses its scheduled time is a discarded freeze-dry. On-site removes both failure modes entirely.
Worked example: reactor manifold, lyo line, and tablet coater
Reactor manifold
50 SCFH @ 99.99%
Lyo backfill peak
200 SCFH @ 99.999%
Tablet coater
50 SCFH @ 99%
Sized at 99.999%
~300 SCFH
If the same generator supplies all three from a common buffer, the system has to be rated at 99.999% across the rolled-up flow because the lyo line drives the spec. Sustained-plus-buffer demand is around 250 to 300 SCFH at 99.999%, which lands on a mid-cabinet running on roughly 30 SCFM of compressed air. If only the lyo line truly needs 99.999%, sizing the main generator to 99.99% across the reactor and coater and running a small dedicated cabinet for the lyo backfill is often the cheaper installed-cost option, with a smaller compressor footprint plant-wide.
Frequently Asked Questions
Medicinal manufacturing nitrogen FAQ
What purity does medicinal manufacturing typically need?
It spans the full tier range by process. Reactor blanketing on standard APIs runs at 99%. General inerting and EO sterilizer backfill run at 99.5%. Oxygen-sensitive APIs, isolator inerting, and lyo backfill on standard injectables run at 99.99%. Biologics lyophilization with tight residual oxygen specs, vaccine fill, and monoclonal antibody fill run at 99.999% and above. The system is sized to the highest purity any one line actually needs.
Can on-site nitrogen replace USP-grade delivered gas?
The generator produces nitrogen that meets the purity specification you set, up to 99.9995%. USP-grade designation is determined by your quality process: documentation, validation, and process-gas qualification are owned by your quality team, the same as with delivered gas. The built-in oxygen analyzer provides the continuous purity record that qualification work draws on.
How does on-site nitrogen support batch records and validation?
On-site PSA generates a continuous, single-source gas at nameplate purity, which is easier to document in a batch record than a cylinder bank rotated by a supplier. Every system includes a built-in oxygen analyzer continuously logging buffer-tank purity, so each batch record can attach a continuous purity log. Equipment qualification covers the generator and its analyzer once, rather than re-qualifying every cylinder lot or supplier change.
Can the same generator supply reactor blanketing and lyophilization backfill?
Often, yes, with one design constraint: the generator has to be sized to the highest purity any process needs. If blanketing runs at 99.99% and lyo backfill needs 99.999%, the system has to be rated at 99.999% across the full rolled-up flow. A common buffer tank covers the lyo cycle peak. If the lyo line is the only process that truly needs 99.999%, a small dedicated cabinet for the backfill is often the cheaper installed-cost option.
Can a nitrogen generator run during a power outage?
No. A PSA nitrogen generator requires electrical power and compressed air to produce nitrogen. Operations that cannot tolerate any supply interruption add a liquid nitrogen backup system that maintains flow until power returns. Ask us to include backup planning in your quote.
What is the typical payback versus bulk liquid nitrogen?
Most medicinal manufacturing installations recover the system investment in 12 to 14 months, driven by displaced deliveries, eliminated tank rental and boil-off losses, and avoided batch interruptions on multi-hour reactor runs and lyo cycles. Operating cost falls up to 90 percent versus delivered gas. After payback, the cost basis is electricity to run the compressor and routine filter changes, and the system is rated for 20 years or more of service life.
Get a Sized Quote
Send the process list. We will size against your existing shop air.
A typical sized-quote conversation takes 10 to 15 minutes once we have the basics. The numbers we need to scope a medicinal production system:
- Process list with peak nitrogen flow per point of use (SCFH or SCFM)
- Required purity per process (reactor / lyo / fill line / coater / isolator / sterilizer)
- Required pressure at point of use (PSIG at manifold or chamber inlet)
- Existing plant compressor capacity and dewpoint, if any
- Current monthly cylinder, dewar, or bulk delivery volume and supplier line items
If you don't have these numbers
A two-week flow-meter baseline replaces the guesswork
Plants on bulk or cylinder service often do not have a clean read on actual peak flow. We rent a flow meter with a cellular data logger that installs at the existing nitrogen header and streams live to a web dashboard throughout the rental, capturing peaks across two weeks of normal operations to produce a baseline curve that sizes the generator without overshoot.
The reading replaces guesswork on cylinder swap rate, chamber-cycle math, or dewar consumption averages.
Medicinal Manufacturing Coverage
Sized for the medicinal operations that run on continuous nitrogen
From single-line API plants to multi-suite biologics and vaccine manufacturing, the generators we supply are sized to the actual rolled-up plant flow at the highest purity any process needs. Continuous purity at the manifold, batch-record-ready purity logging from the built-in oxygen analyzer, no cylinder rotation during a multi-day cycle.